0FR847Z
Replacement Cystic Duct to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | R Replacement |
| Body Part | 8 Cystic Duct |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures in this body system involve putting in biological or synthetic material that physically takes over for hepatobiliary or pancreatic tissue that has been removed or has failed. This is less common here than in joints or vessels, but it appears in cases such as reconstructing a resected segment of common bile duct with a synthetic conduit, or substituting a portion of the biliary tree with harvested tissue when the native duct cannot be repaired or reconnected directly.
The goal is to restore the physical pathway or structural function that the original tissue provided, most often maintaining bile flow from the liver to the intestine after injury, tumor removal, or failed prior surgery. Because these are structurally significant reconstructions, they're typically performed as part of a larger operation rather than as standalone procedures.
Anatomy & Axis Detail
Cystic Duct
The cystic duct connects the gallbladder to the common hepatic duct and is ordinarily divided and ligated during cholecystectomy rather than reconstructed, so replacement coding here is reserved for the unusual circumstance in which a segment of this duct is excised and substituted with graft material, such as during complex reconstructive surgery following extensive injury to the biliary confluence. Its short length and small diameter limit how often it is treated as an independent structure requiring replacement, since most reconstructive procedures in this area target the adjacent common bile or hepatic ducts instead. When this code does apply, operative documentation should clearly identify that the cystic duct itself, distinct from the neighboring ducts it joins, was the segment replaced with graft tissue.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders should look for explicit documentation that a graft, conduit, or other material was used to physically stand in for tissue that was excised or was not repairable in place. The operative report needs to state what was removed, what material replaced it, and where it was anastomosed. A common mistake is coding Replacement when the surgeon actually reconstructed continuity using the patient's own repositioned tissue, such as a Roux-en-Y hepaticojejunostomy, which is typically coded differently since bowel is being connected rather than biliary tissue being replaced. Confirming the material type (autograft, synthetic, or nonautologous) also matters for accurate device character assignment.